Shared on15 Aug 25Fair value Increased 10%
Analysts raised their price target for SANUWAVE Health from $49.00 to $54.00 following strong Q2 results, upward revisions to FY25 AEBITDA and continued revenue guidance confidence, reflecting increased conviction in profitability and growth. Analyst Commentary Bullish analysts cited strong Q2 results as a key driver for the price target increase.